BMRN three-lens brief
Evidence-based stock research on BMRN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.10% yesterday. · P/E of 152 — priced for high growth; little margin of safety.
- Moved +2.10% yesterday.
- P/E of 152 — priced for high growth; little margin of safety.
- Analyst mean target $90.78 — 56% above current (27 analysts).
- Negative free cash flow last quarterly (-$16.04M).
- Reported earnings on 2026-11-02.
BMRN closed at $58.33 (+2.10%) as of 2026-11-12. Market cap: $11.30B. P/E (trailing) 151.6. Price is below the 50-day MA and below the 200-day MA. Positives: moved +2.10% yesterday.; analyst mean target $90.78 — 56% above current (27 analysts).. Concerns: p/E of 152 — priced for high growth; little margin of safety.; negative free cash flow last quarterly (-$16.04M).. Last quarter: Revenue $1.02B, net income -$122.83M, free cash flow -$16.04M.
Why three lenses on BMRN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BMRN across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BMRN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BMRN brief"></iframe>